These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32154156)

  • 41. Inhibition of acyl coenzyme A:cholesterol acyl transferase in J774 macrophages enhances down-regulation of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase and prevents low density lipoprotein-induced cholesterol accumulation.
    Tabas I; Weiland DA; Tall AR
    J Biol Chem; 1986 Mar; 261(7):3147-55. PubMed ID: 3949765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the esterification of cholesterol in human long term lymphoid cell lines.
    Kayden HJ; Hatam L; Beratis NG
    Biochemistry; 1976 Feb; 15(3):521-8. PubMed ID: 1252410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of sepsis on the metabolism of sphingomyelin and cholesterol in mice with liver dysfunction.
    Li J; Xia K; Xiong M; Wang X; Yan N
    Exp Ther Med; 2017 Dec; 14(6):5635-5640. PubMed ID: 29285103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-density lipoproteins negatively regulate innate immunity and facilitate red-spotted grouper nervous necrosis virus entry via scavenger receptor B type 1.
    Han H; Wang Y; Xu S; Han C; Qin Q; Wei S
    Int J Biol Macromol; 2022 Aug; 215():424-433. PubMed ID: 35752331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.
    Kuo KK; Wu BN; Liu CP; Yang TY; Kao LP; Wu JR; Lai WT; Chen IJ
    J Lipid Res; 2015 Nov; 56(11):2070-84. PubMed ID: 26351364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the polyphenol-rich extract from Allium cepa on hyperlipidemic sprague-dawley rats.
    Li W; Yang C; Mei X; Huang R; Zhang S; Tang Y; Dong Q; Zhou C
    J Food Biochem; 2021 Jan; 45(1):e13565. PubMed ID: 33219537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvianolic acid A alleviates atherosclerosis by inhibiting inflammation through Trc8-mediated 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation.
    Xie D; Song L; Xiang D; Gao X; Zhao W
    Phytomedicine; 2023 Apr; 112():154694. PubMed ID: 36804757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
    Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDL in atherosclerosis: actor or bystander?
    Asztalos BF; Schaefer EJ
    Atheroscler Suppl; 2003 Mar; 4(1):21-9. PubMed ID: 12714034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1.
    Fung KYY; Ho TWW; Xu Z; Neculai D; Beauchemin CAA; Lee WL; Fairn GD
    J Lipid Res; 2024 Apr; 65(4):100530. PubMed ID: 38479648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes.
    Shefer S; Salen G; Bullock J; Nguyen LB; Ness GC; Vhao Z; Belamarich PF; Chowdhary I; Lerner S; Batta AK
    Hepatology; 1994 Jul; 20(1 Pt 1):213-9. PubMed ID: 8020891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitubercular triterpenes and phytosterols from Pandanus tectorius Soland. var. laevis.
    Tan MA; Takayama H; Aimi N; Kitajima M; Franzblau SG; Nonato MG
    J Nat Med; 2008 Apr; 62(2):232-5. PubMed ID: 18404330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR) protects hair cells from cisplatin-induced ototoxicity in vitro: possible relation to the activities of p38 MAPK signaling pathway.
    Li Y; Yang H; Nong H; Wang F; Wang Y; Xu Y; Zhang J; Zhao H; Cao Z; Yang Q; Li J
    Arch Toxicol; 2023 Nov; 97(11):2955-2967. PubMed ID: 37608195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigallocatechin-3-gallate (EGCG) inhibits 3-hydroxy-3-methylglutaryl-CoA reductase in the presence of glycerol.
    Wu Q; Li JZ; Zhao TY; Li TB; Wang JX; Sui Y; Ma JF; Li WN; Gao XF; Xing S; Fu XQ
    Pak J Pharm Sci; 2014 Nov; 27(6):1905-10. PubMed ID: 25362614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
    Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
    Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver.
    Hwang S; Hartman IZ; Calhoun LN; Garland K; Young GA; Mitsche MA; McDonald J; Xu F; Engelking L; DeBose-Boyd RA
    J Biol Chem; 2016 Jun; 291(26):13479-94. PubMed ID: 27129778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance.
    Loh K; Tam S; Murray-Segal L; Huynh K; Meikle PJ; Scott JW; van Denderen B; Chen Z; Steel R; LeBlond ND; Burkovsky LA; O'Dwyer C; Nunes JRC; Steinberg GR; Fullerton MD; Galic S; Kemp BE
    Hepatol Commun; 2019 Jan; 3(1):84-98. PubMed ID: 30619997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.